Deutsche Bank Ag\ Medi Wound Ltd. Transaction History

Deutsche Bank Ag\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$1.57 - $3.1 $4,585 - $9,055	-2,921 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.72 - $3.15 $7,945 - $9,201	2,921 New	2,921 $9,000
Q2 2019 Aug 14, 2019	SELL	$3.0 - $5.5 $193,500 - $354,750	-64,500 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$4.24 - $5.24 $104,982 - $129,742	24,760 Added 62.3%	64,500 $322,000
Q4 2018 Feb 14, 2019	BUY	$3.95 - $6.55 $66,518 - $110,302	16,840 Added 73.54%	39,740 $161,000
Q3 2018 Nov 14, 2018	BUY	$6.1 - $7.1 $139,690 - $162,590	22,900 New	22,900 $140,000

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $683M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.